FTSE MIB
34.492,41 +44,84 (+0,13%) Dow Jones
38.686,32 +574,84 (+1,51%) Nasdaq
16.735,02 -2,06 (-0,01%) Nikkei 225
38.487,90 +433,77 (+1,14%) Petrolio
77,18 -0,73 (-0,94%) Bitcoin EUR
62.402,34 +349,57 (+0,56%)
Pharming Group N.V. (PHARM.AS)
| Chiusura precedente | 0,8225 |
| Aperto | 0,7900 |
| Denaro | 0,0000 x 0 |
| Domanda | 0,0000 x 0 |
| Min-Max giorno | 0,7220 - 0,8240 |
| Intervallo di 52 settimane | 0,7220 - 1,3130 |
| Volume | |
| Media Volume | 6.721.681 |
| Capitalizzazione | 552,556M |
| Beta (mensile su 5 anni) | 0,76 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,0100 |
| Prossima data utili | 01 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 1,77 |
GlobeNewswirePharming Group to report third quarter 2023 financial results on October 26
Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2023 financial results, for the period ended September 30, on Thursday, October 26, 2023. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 EDT on October 26, 2023. To participate in the conference call, please register in advance using the link below. Once registered, dial-in informat
- GlobeNewswire
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. Deborah Jorn, Vice-Chair of the
